Walter J. Curran receives first NRG Oncology Gold Medal Award

Charles Geyer named associate group chair of NRG Oncology

The NRG Oncology Group Chairs created the position of associate group chair and selected Charles E. Geyer to fill the position, effective immediately. He will serve alongside the three NRG Oncology group chairs, Quynh-Thu Le, Robert Mannel, and Norman Wolmark.

February 21, 2025

Vol.51 No.07

Obituary

Feng’s team advanced the understanding of biomarkers in prostate cancer

The late Felix Feng, MD (center) with researchers Jonathan Chou, MD, PhD (left) and Lisa Chesner, PhD (right), in 2019.Photo by Noah BergerFelix Y. Feng, a genitourinary cancer research leader, died on Dec. 10, 2024. He was 48.This article is republished with permission by NRG Oncology.Dr. Feng was the former NRG Oncology Genitourinary Cancer Committee chair and an RTOG Foundation member. After years of dedicated and enthusiastic commitment to the NRG and previously the RTOG Genitourinary Cancer Committee, chairing or co-chairing 13 research protocols for NRG and RTOG, Dr. Feng was appointed committee chair in March 2018, following in the footsteps of Dr. Howard Sandler, his mentor. Dr. Feng was also a member of the RTOG Foundation Board of Directors.

January 24, 2025

Vol.51 No.03

By NRG Staff

In Brief

Michalski, Ng, Sartor, Hawley, and Yeku named to leadership roles at NRG Oncology

NRG Oncology recently announced the creation of a new Theranostics Subcommittee, as well as two leadership role updates within the organization’s current committees.

January 10, 2025

Vol.51 No.01

Guest Editorial

Group chairs propose funding strategy to jump-start correlative studies

The National Academy of Medicine recognized the value of correlative science in publicly funded clinical trials in 2010, recommending “the incorporation of innovative science into cancer clinical trials through the support and use of biorepositories.”

Accelerated partial-breast irradiation is not statistically equivalent to whole-breast irradiation in local tumor control, NRG oncology trial shows

The NRG Oncology NSABP B-39/RTOG 0413 clinical trial compared whole-breast irradiation to accelerated partial-breast irradiation and determined that APBI was not statistically equivalent to WBI in local tumor control. The secondary outcome for the trial was quality-of-life.

September 20, 2024

Vol.50 No.35

In Brief

Nguyen, Ayala-Peacock, Gaillard, Corr named leaders of three NRG committees

Paul L. NguyenDiandra N. Ayala-PeacockStéphanie GaillardBradley CorrNRG Oncology named a new chair to the NRG Genitourinary Cancer Committee, a new vice-chair of the NRG Radiation Oncology Committee, and a new chair and vice-chair of the NRG Developmental Therapeutics Gynecologic Cancer Phase I Subcommittee.

May 24, 2024

Vol.50 No.21